{
    "clinical_study": {
        "@rank": "13219", 
        "arm_group": [
            {
                "arm_group_label": "High Flow Conditioned Oxygen Therapy", 
                "arm_group_type": "Experimental", 
                "description": "Intervention: The Optiflow(R) device supplies oxygen in controlled concentrations and at high flow (from 10 to 70 liters/min) through special nasal cannulae. The device also humidifies the gases mixtures up to 100% relative humidity."
            }, 
            {
                "arm_group_label": "Standard Oxygen Therapy", 
                "arm_group_type": "Active Comparator", 
                "description": "The standard way of oxygen supply after extubation is either by nasal cannulae at flow between 1 and 5 liters/min or by mask with controlled oxygen concentration from 24% to 50%."
            }
        ], 
        "brief_summary": {
            "textblock": "Failure of extubation after mechanical ventilation is a frequent and deleterious issue. Main\n      reasons for failure are hypoxemia, secretions retention, lung collapse and excessive work of\n      breathing. Most of this issues can be partly counterbalanced by a device named \"High flow\n      conditioned oxygen therapy (HFCO)\". Then, our hypothesis is that HFCO may reduce the\n      incidence of respiratory failure after extubation in patients with high risk for failure."
        }, 
        "brief_title": "Extubation Failure Prevention in High Risk Patients by High-flow Conditioned Oxygen Therapy vs. Standard Oxygen Therapy", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Respiratory Failure", 
        "condition_browse": {
            "mesh_term": "Respiratory Insufficiency"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients mechanically ventilated for > 48 hours and at least one of the following:\n\n          -  >65 years\n\n          -  cardiac failure as the primary indication of mechanical ventilation\n\n          -  Chronic Obstructive Pulmonary Disease\n\n          -  Severity score (APACHE II >12 points) the extubation day\n\n          -  Body Mass Index >30\n\n          -  inability to manage respiratory secretions\n\n          -  1 failed spontaneous breathing trial\n\n          -  1 comorbidity\n\n          -  7 days under mechanical ventilation\n\n        Exclusion Criteria:\n\n          -  <18 years\n\n          -  tracheotomized patients\n\n          -  recent facial or cervical trauma/surgery\n\n          -  active gastro-intestinal bleeding\n\n          -  lack of cooperation\n\n          -  patients with any failed spontaneous breathing trial because of hypercapnia\n             development."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "95 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01820507", 
            "org_study_id": "CEIC 12/85"
        }, 
        "intervention": [
            {
                "arm_group_label": "High Flow Conditioned Oxygen Therapy", 
                "description": "The described method of oxygen supply will be maintained continuously for the first 24 hours after extubation.", 
                "intervention_name": "Optiflow (Fisher&Paykel)", 
                "intervention_type": "Device", 
                "other_name": "High Flow Conditioned Oxygen Therapy"
            }, 
            {
                "arm_group_label": "Standard Oxygen Therapy", 
                "description": "The described method of oxygen supply will be maintained continuously for the first 24 hours after extubation.", 
                "intervention_name": "Nasal cannulae or controlled oxygen concentration mask", 
                "intervention_type": "Device", 
                "other_name": "Standard Oxygen Therapy"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Post-extubation respiratory failure", 
            "Endotracheal intubation", 
            "Mechanical ventilation"
        ], 
        "lastchanged_date": "November 28, 2013", 
        "location": {
            "contact": {
                "email": "rfernandezf@althaia.cat", 
                "last_name": "Rafael Fernandez, MD", 
                "phone": "34.938732112", 
                "phone_ext": "3216"
            }, 
            "facility": {
                "address": {
                    "city": "Manresa", 
                    "country": "Spain", 
                    "state": "Barcelona", 
                    "zip": "08242"
                }, 
                "name": "ICU. Fundacio Althaia"
            }, 
            "investigator": [
                {
                    "last_name": "Rafael Fernandez, MD", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Carles Subira, MD", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Spain"
        }, 
        "number_of_arms": "2", 
        "official_title": "Prevention of Post-extubation Respiratory Failure in High Risk Patients by High-flow Conditioned Oxygen Therapy Versus Standard Oxygen Therapy", 
        "overall_official": {
            "affiliation": "Fundacio Althaia", 
            "last_name": "Rafael Fernandez, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "March 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Severe hypoxemia (PaO2/Fraction of inspired O2 < 200), hypercapnia (PaCO2 > 50), respiratory acidosis (arterial pH < 7.30), severe tachypnea (>40x')", 
            "measure": "Respiratory failure after extubation", 
            "safety_issue": "Yes", 
            "time_frame": "72 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01820507"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Althaia Xarxa Assistencial Universit\u00e0ria de Manresa", 
            "investigator_full_name": "Rafael Fernandez", 
            "investigator_title": "Head of Intensive Care Department", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Survival", 
            "safety_issue": "Yes", 
            "time_frame": "90 days"
        }, 
        "source": "Althaia Xarxa Assistencial Universit\u00e0ria de Manresa", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Althaia Xarxa Assistencial Universit\u00e0ria de Manresa", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}